4-1BB is a target for immunotherapy in patients with undifferentiated pleomorphic sarcoma
Miriam J Melake, Henry G Smith, David Mansfield, Emma Davies, Magnus T Dillon, Anna C Wilkins, Emmanuel C Patin, Malin Pedersen, Richard Buus, Aisha B Miah, Shane H Zaidi, Khin Thway, Alan A Melcher, Andrew J Hayes, Tim R Fenton, , Martin McLaughlin
The paper identifies 4-1BB as a potential immunotherapy target in undifferentiated pleomorphic sarcoma by analyzing patient cohorts and TCGA data.
bioRxiv · Jul 10, 2020 · PreprintCancer Biology